Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories

BACKGROUND: Mutations in the KRAS gene are associated with poor response to epidermal growth factor receptor inhibitors used in the treatment of metastatic colorectal cancer. Factors influencing KRAS test results in tumor specimens include: tumor heterogeneity, sample handling, slide preparation, te...

Descripción completa

Detalles Bibliográficos
Autores principales: Feigelson, Heather Spencer, Goddard, Katrina AB, Johnson, Monique A, Funk, Kellyan C, Rahm, Alanna Kulchak, Kauffman, Tia L, Chitale, Dhananjay A, Le Marchand, Loic, Richards, C Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441241/
https://www.ncbi.nlm.nih.gov/pubmed/22534075
http://dx.doi.org/10.1186/1756-0500-5-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441241/
https://www.ncbi.nlm.nih.gov/pubmed/22534075
http://dx.doi.org/10.1186/1756-0500-5-196

Ejemplares similares